FIELD: organic chemistry.
SUBSTANCE: method for producing thio derivatives of pyrrolidine-2,5-diones with a quinazoline fragment of general Formula (I), exhibiting antiviral inhibitory activity against the main protease Mpro of the beta coronavirus SARS-CoV-2. In the general Formula I, R1 is phenyl; R2, R3, R4 represent a substituent selected from hydrogen, C1-C2 alkyl, C1-C2 alkoxy, chlorine; R5 is naphthyl or phenyl, optionally substituted once or twice with C1-C2 alkyl, halogen, methoxy, ethoxy. The method consists of first adding 1-3 drops of triethylamine to a solution containing 0.01 mol of the corresponding 2-mercaptoquinazoline and 20 ml of absolute methanol, then adding in small portions from 0.01 to 0.011 mol of N-arylmaleimide, the resulting reaction mixture is stirred for 1 h, boiled for 3-4 h, cooled, the precipitate is filtered off and recrystallized from methanol.
EFFECT: obtaining thio derivatives of pyrrolidine-2,5-diones with a quinazoline fragment in high yields (up to 88%) using a simple procedure for their isolation from the reaction mass by simple filtration without the use of more labor-intensive chromatographic methods.
1 cl, 1 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF AN OXYGEN-CONTAINING DERIVATIVE OF 6-HALOQUINOLINE FOR INHIBITING THE REPLICATION OF BETACORONAVIRUSES, INCLUDING SARS-COV-2, AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2780245C1 |
APPLICATION OF A DERIVATIVE OF 1,3,5-TRIAZINE-2,4-DIAMINE FOR INHIBITING THE REPLICATION OF BETACORONAVIRUSES, INCLUDING SARS-COV-2 | 2021 |
|
RU2780249C1 |
APPLICATION OF A TRICYCLIC SULPHUR-CONTAINING DERIVATIVE OF 1,2-DIHYDROQUINOLINE FOR INHIBITING THE REPLICATION OF BETACORONAVIRUSES, INCLUDING SARS-COV-2 | 2021 |
|
RU2780247C1 |
PHARMACEUTICAL COMPOSITION, INCLUDING TRICYCLIC SULFUR-CONTAINING 1,2-DIHYDROQUINOLINE DERIVATIVE FOR INHIBITION OF REPLICATION OF BETA CORONAVIRUSES, INCLUDING SARS-CoV-2, AND METHOD OF ITS USE | 2021 |
|
RU2814434C1 |
METHOD OF PRODUCING A TRICYCLIC SULFUR-CONTAINING DERIVATIVE OF 1,2-DIHYDROQUINOLINE FOR INHIBITING REPLICATION OF BETA-CORONAVIRUSES, INCLUDING SARS-CoV-2 | 2021 |
|
RU2819783C1 |
LIPOSOMAL COMPOSITION OF 5-CHLOROPYRIDIN-3-IL-1H-INDOL-4-CARBOXYLATE AS A POTENTIAL EMERGENCY PREVENTION AND TREATMENT OF CORONAVIRUS INFECTIONS | 2023 |
|
RU2810261C1 |
5-[4-(1,3-BENZOTHIAZOL-2-YL)PHENYL]-10,15,20-TRIS(1-METHYLPYRIDINIUM-3-YL)PORPHYRIN TRIIOODIDE, SHOWING THE BINDING PROPERTY OF THE SARS-CoV-2 VIRUS SPIKE PROTEIN | 2021 |
|
RU2773397C1 |
HERBAL TEA COMPOSITION | 2022 |
|
RU2795879C1 |
USE OF SUBSTITUTED 2-(2-(4,4,6-TRIMETHYL-2-OXO-4N-PYRROLO[3,2,1-IJ]QUINOLINE-1(2H)-YLIDENE)HYDRAZINYL)THIAZOLE-4(5H)-ONES AS INHIBITORS OF BLOOD COAGULATION FACTORS XA AND XIA AND METHOD FOR THEIR PREPARATION | 2023 |
|
RU2819271C1 |
IMPROVED METHOD OF PRODUCING 5-CHLOROPYRIDIN-3-YL-1N-INDOLE-4-CARBOXYLATE | 2023 |
|
RU2816391C1 |
Authors
Dates
2023-11-09—Published
2021-04-30—Filed